drugset / Trial / NCT04189705
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multi-center, randomized, double-blind, active-controlled, non-inferiority, phase 3 study to evaluate the efficacy and safety of MCT-SR in patients with gastritis.
Timeline
- Start
- 2019-12-30
- Primary completion
- 2020-04-23
- Completion
- 2020-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rebamipide | Small molecule | 100 mg | — |
| Subject | Rebamipide | Small molecule | 150 mg | — |